Moderate

Perianal Crohn's disease

Perianal CD · Gastroenterology
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

Fistulising/abscess-forming perianal disease is a disabling Crohn's phenotype needing combined medical and surgical management; MRI defines anatomy and anti-TNF therapy with seton drainage is the mainstay.

Red flags

  • Undrained perianal abscess (sepsis)
  • Increasing pain, swelling, fever
  • Faecal incontinence (sphincter involvement)
  • Suspicion of anorectal cancer in longstanding fistula

Assessment

Differential diagnosis

  • Cryptoglandular (non-Crohn's) perianal fistula/abscess
  • Hidradenitis suppurativa
  • Anorectal malignancy
  • Sexually transmitted proctitis (LGV)
  • Tuberculous fistula

Investigations

  • Pelvic MRI (fistula anatomy, abscess, classification)
  • Examination under anaesthesia by colorectal surgeon
  • Endoscopy to assess rectal inflammation
  • Faecal calprotectin, CRP, FBC
  • Hepatitis B/C, TB, VZV screen before biologics

Management

  • Confirm Crohn's and assess rectal/luminal disease activity
  • Obtain pelvic MRI to map fistula tracts and detect abscess
  • Arrange examination under anaesthesia with drainage of any abscess and seton placement
  • Control sepsis before/alongside immunosuppression — never immunosuppress undrained sepsis
  • Start an anti-TNF biologic (infliximab first-line) as the key medical therapy
  • Combine with a thiopurine to optimise biologic levels and durability where appropriate
  • Add an antibiotic course (metronidazole ± ciprofloxacin) for active sepsis/symptoms
  • Treat concurrent rectal inflammation to improve fistula healing
  • Use therapeutic drug monitoring — perianal disease needs higher biologic trough levels
  • Consider definitive surgery (fistulotomy for simple tracts; advancement flap, LIFT, or stem cells for complex) once inflammation controlled
  • Reassess with repeat MRI before removing setons; long-term maintenance therapy and surveillance

Drugs & doses

Infliximab 5 mg/kg IV at 0, 2, 6 weeks then 8-weekly (aim higher trough levels)
Metronidazole 400 mg PO three times daily
Ciprofloxacin 500 mg PO twice daily
Azathioprine 2–2.5 mg/kg PO once daily (combination)

Disposition

Joint IBD-colorectal MDT; EUA and seton by colorectal surgery, medical therapy by IBD team.

Complications & pitfalls

  • Recurrent perianal sepsis/abscess
  • Anal sphincter damage and incontinence
  • Rectovaginal fistula
  • Anorectal carcinoma (longstanding fistula)
  • Proctectomy/stoma for refractory disease

Exam pearls

  • Always drain sepsis and place setons BEFORE escalating immunosuppression
  • Perianal fistulising Crohn's needs higher anti-TNF trough levels than luminal disease
  • MRI is the standard for mapping tracts and confirming healing before seton removal
  • Combination anti-TNF plus thiopurine improves fistula outcomes

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.